Cargando…
GM-CSF Treated F4/80(+) BMCs Improve Murine Hind Limb Ischemia Similar to M-CSF Differentiated Macrophages
Novel cell therapy is required to treat critical limb ischemia (CLI) as many current approaches require repeated aspiration of bone marrow cells (BMCs). The use of cultured BMCs can reduce the total number of injections required and were shown to induce therapeutic angiogenesis in a murine model of...
Autores principales: | Kuwahara, Go, Nishinakamura, Hitomi, Kojima, Daibo, Tashiro, Tadashi, Kodama, Shohta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159294/ https://www.ncbi.nlm.nih.gov/pubmed/25202910 http://dx.doi.org/10.1371/journal.pone.0106987 |
Ejemplares similares
-
G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990) -
GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019) -
A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014) -
Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023) -
GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019)